Debra P. Merrill

905 total citations
16 papers, 742 citations indexed

About

Debra P. Merrill is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Debra P. Merrill has authored 16 papers receiving a total of 742 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Virology, 14 papers in Infectious Diseases and 3 papers in Immunology. Recurrent topics in Debra P. Merrill's work include HIV Research and Treatment (16 papers), HIV/AIDS drug development and treatment (14 papers) and HIV/AIDS Research and Interventions (10 papers). Debra P. Merrill is often cited by papers focused on HIV Research and Treatment (16 papers), HIV/AIDS drug development and treatment (14 papers) and HIV/AIDS Research and Interventions (10 papers). Debra P. Merrill collaborates with scholars based in United States, Spain and Italy. Debra P. Merrill's co-authors include Ting‐Chao Chou, Martin Hirsch, M. S. Hirsch, Victoria A. Johnson, Joseph J. Eron, Richard T. D’Aquila, Mona Moonis, Stefano Rusconi, Joan C. Kaplan and Martin S. Hirsch and has published in prestigious journals such as Nature, Journal of Clinical Microbiology and The Journal of Infectious Diseases.

In The Last Decade

Debra P. Merrill

16 papers receiving 692 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Debra P. Merrill United States 12 573 558 132 94 89 16 742
M. B. Vasudevachari United States 12 693 1.2× 550 1.0× 196 1.5× 140 1.5× 126 1.4× 21 861
Marie K. Mankowski United States 15 402 0.7× 345 0.6× 101 0.8× 88 0.9× 176 2.0× 23 604
Bonnie Spira Canada 11 718 1.3× 790 1.4× 178 1.3× 57 0.6× 117 1.3× 17 915
Mary O’Hearn United States 6 599 1.0× 676 1.2× 136 1.0× 115 1.2× 106 1.2× 9 838
Jingyun Li China 18 814 1.4× 724 1.3× 301 2.3× 176 1.9× 79 0.9× 90 1.1k
N. Bischofberger United States 14 527 0.9× 580 1.0× 322 2.4× 160 1.7× 182 2.0× 24 930
Christian Tourrès France 15 604 1.1× 556 1.0× 160 1.2× 69 0.7× 92 1.0× 25 742
G Croteau Canada 9 478 0.8× 516 0.9× 59 0.4× 264 2.8× 130 1.5× 14 874
Maria Cecília Araripe Sucupira Brazil 18 646 1.1× 654 1.2× 252 1.9× 102 1.1× 118 1.3× 59 966
Mona Moonis India 8 262 0.5× 244 0.4× 72 0.5× 75 0.8× 45 0.5× 11 396

Countries citing papers authored by Debra P. Merrill

Since Specialization
Citations

This map shows the geographic impact of Debra P. Merrill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debra P. Merrill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debra P. Merrill more than expected).

Fields of papers citing papers by Debra P. Merrill

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Debra P. Merrill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debra P. Merrill. The network helps show where Debra P. Merrill may publish in the future.

Co-authorship network of co-authors of Debra P. Merrill

This figure shows the co-authorship network connecting the top 25 collaborators of Debra P. Merrill. A scholar is included among the top collaborators of Debra P. Merrill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Debra P. Merrill. Debra P. Merrill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Rusconi, Stefano, Debra P. Merrill, Elisabetta Bulgheroni, et al.. (2000). In Vitro Inhibition of HIV-1 by Met-Sdf-1β Alone or in Combination with Antiretroviral Drugs. Antiviral Therapy. 5(3). 199–204. 7 indexed citations
2.
Tremblay, Cécile, Françoise Giguel, Debra P. Merrill, et al.. (2000). Marked Differences in Quantity of Infectious Human Immunodeficiency Virus Type 1 Detected in Persons with Controlled Plasma Viremia by a Simple Enhanced Culture Method. Journal of Clinical Microbiology. 38(11). 4246–4248. 7 indexed citations
3.
Merrill, Debra P., Javier Martínez‐Picado, Cécile Tremblay, et al.. (1999). Improved CD4 Lymphocyte Outgrowth in Response to Effective Antiretroviral Therapy. The Journal of Infectious Diseases. 179(2). 345–351. 6 indexed citations
4.
Tremblay, Cécile, Debra P. Merrill, Ting‐Chao Chou, & Martin Hirsch. (1999). Interactions Among Combinations of Two and Three Protease Inhibitors Against Drug-Susceptible and Drug-Resistant HIV-1 Isolates. JAIDS Journal of Acquired Immune Deficiency Syndromes. 22(5). 430–430. 13 indexed citations
5.
Oh, Myoung‐don, Debra P. Merrill, Lorraine Sutton, & Martin Hirsch. (1997). Sequential versus Simultaneous Combination Antiretroviral Regimens for the Treatment of Human Immunodeficiency Virus Type 1 Infection In Vitro. The Journal of Infectious Diseases. 176(2). 510–514. 3 indexed citations
6.
Merrill, Debra P., Douglas J. Manion, Ting‐Chao Chou, & Martin Hirsch. (1997). Antagonism between Human Immunodeficiency Virus Type 1 Protease Inhibitors Indinavir and Saquinavir In Vitro. The Journal of Infectious Diseases. 176(1). 265–268. 27 indexed citations
7.
Merrill, Debra P., Mona Moonis, Ting‐Chao Chou, & M. S. Hirsch. (1996). Lamivudine or Stavudine in Two- and Three-Drug Combinations against Human Immunodeficiency Virus Type 1 Replication In Vitro. The Journal of Infectious Diseases. 173(2). 355–364. 76 indexed citations
8.
Rusconi, Stefano, Mona Moonis, Debra P. Merrill, et al.. (1996). Naphthalene sulfonate polymers with CD4-blocking and anti-human immunodeficiency virus type 1 activities. Antimicrobial Agents and Chemotherapy. 40(1). 234–236. 131 indexed citations
9.
Wilson, Cara C., Johnson T. Wong, D Girard, et al.. (1995). Ex Vivo Expansion of CD4 Lymphocytes from Human Immunodeficiency Virus Type 1-Infected Persons in the Presence of Combination Antiretroviral Agents. The Journal of Infectious Diseases. 172(1). 88–96. 37 indexed citations
10.
Rusconi, Stefano, Debra P. Merrill, & M. S. Hirsch. (1994). Inhibition Of Human Immunodeficiency Virus Type 1 Replication In Cytokinestimulated Monocytesjmacrophages By Combination Therapy. The Journal of Infectious Diseases. 170(6). 1361–1366. 21 indexed citations
11.
Mazzulli, Tony, Stefano Rusconi, Debra P. Merrill, et al.. (1994). Alternating versus continuous drug regimens in combination chemotherapy of human immunodeficiency virus type 1 infection in vitro. Antimicrobial Agents and Chemotherapy. 38(4). 656–661. 23 indexed citations
12.
Hirsch, Martin S., Debra P. Merrill, Lawrence Bechtel, et al.. (1993). Use of evolutionary limitations of HIV-1 multidrug resistance to optimize therapy. Nature. 361(6413). 650–654. 113 indexed citations
13.
Johnson, Victoria A., Debra P. Merrill, Ting‐Chao Chou, & Martin Hirsch. (1992). Human Immunodeficiency Virus Type 1 (HIV-1) Inhibitory Interactions between Protease Inhibitor Ro 31-8959 and Zidovudine, 2',3'-Dideoxycytidine, or Recombinant Interferon- A against Zidovudine-Sensitive or -Resistant HIV-1 In Vitro. The Journal of Infectious Diseases. 166(5). 1143–1146. 53 indexed citations
14.
Eron, Joseph J., Victoria A. Johnson, Debra P. Merrill, Ting‐Chao Chou, & Martin Hirsch. (1992). Synergistic inhibition of replication of human immunodeficiency virus type 1, including that of a zidovudine-resistant isolate, by zidovudine and 2',3'-dideoxycytidine in vitro. Antimicrobial Agents and Chemotherapy. 36(7). 1559–1562. 50 indexed citations
15.
Johnson, Victoria A., Debra P. Merrill, Ting‐Chao Chou, et al.. (1991). Two-Drug Combinations of Zidovudine, Didanosine, and Recombinant Interferon-  A Inhibit Replication of Zidovudine-Resistant Human Immunodeficiency Virus Type 1 Synergistically In Vitro. The Journal of Infectious Diseases. 164(4). 646–655. 115 indexed citations
16.
Johnson, Victoria A., Matthew A Barlow, Debra P. Merrill, Ting‐Chao Chou, & M. S. Hirsch. (1990). Three-Drug Synergistic Inhibition of HIV-l Replication In Vitro by Zidovudine, Recombinant Soluble CD4, and Recombinant Interferon-alpha A. The Journal of Infectious Diseases. 161(6). 1059–1067. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. B. Vasudevachari Breakdown of academic impact, for papers by Marie K. Mankowski Breakdown of academic impact, for papers by Bonnie Spira Breakdown of academic impact, for papers by Mary O’Hearn Breakdown of academic impact, for papers by Jingyun Li Breakdown of academic impact, for papers by N. Bischofberger Breakdown of academic impact, for papers by Christian Tourrès Breakdown of academic impact, for papers by G Croteau Breakdown of academic impact, for papers by Maria Cecília Araripe Sucupira Breakdown of academic impact, for papers by Mona Moonis
Rankless by CCL
2026